跳至主要内容
临床试验/CTRI/2018/07/014771
CTRI/2018/07/014771已完成4 期

EFFECT OF ROSUVASTATIN ON OXIDATIVE STRESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Sri Venkateswara Institute of Medical Sciences0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with T2DM aged between 30-60 years as per the revised ADA
  • (American Diabetic Association) criteria i.e.,(12)
  • i) Fasting plasma glucose =126mg/dL (7.0 mmol/L)
  • ii) 2 hour plasma glucose =200mg/dL (11.1 mmol/L)
  • iii) Glycosylated hemoglobin (HbA1c) >6.5% (48 mmol/mol)

排除标准

  • Patients with other forms of diabetes (T1DM, Gestational diabetes mellitus)
  • Those on insulin therapy
  • Thyroid disorders not on treatment
  • Those on pioglitazone
  • Liver and kidney diseases
  • Other inflammatory diseases
  • Acute illness
  • Current smoking
  • Those on cholesterol lowering drugs
  • Individuals who are not willing to participate

研究者

相似试验

Effect of rosuvastatin in reducing free radical... | 临床试验